Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combined Phase 1 + 2 Clinical Trial Evaluating the Safety and Efficacy of BC-DN-01 in the Treatment of Painful Diabetic Peripheral Neuropathy

NCT01793350 is registered in ClinicalTrials.gov with BioChemics, Inc. as lead sponsor.

NCT NCT01793350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combined Phase 1 + 2 Clinical Trial Evaluating the Safety and Efficacy of BC-DN-01 in the Treatment of Painful Diabetic Peripheral Neuropathy
Lead sponsor
BioChemics, Inc.
Phase
Phase 1/2
Overall status
Withdrawn
Start date
June 30, 2013
Completion date
December 31, 2014
Enrollment
0 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathy, painful